Sensitive and quantitative detection of mutations associated with clinical resistance to STI-571
Authors:
- G.Mike MakrigiorgosGMG.Mike Makrigiorgos
- 1 November 2003
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 27 (11) , 979-982
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Mutation in the ATP‐binding site of BCR‐ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571British Journal of Haematology, 2002
- Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loopProceedings of the National Academy of Sciences, 2002
- High frequency of point mutations clustered within the adenosine triphosphate–binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistanceBlood, 2002
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumorsOncogene, 1999
- Mutation analysis using the restriction site mutation (RSM) assayMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1998
- Genotypic selection methods for the direct analysis of point mutationsMutation Research - Reviews in Mutation Research, 1997
- Genotypic mutation analysis by RFLP/PCRMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- Restriction site mutation analysis, a proposed methodology for the detection and study of DNA base changes following mutagen exposureMutagenesis, 1990
- Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markersNucleic Acids Research, 1989